Preoperative Dehydration Is an Underrecognized Modifiable Risk Factor in Total Hip Arthroplasty.


Journal

Journal of surgical orthopaedic advances
ISSN: 1548-825X
Titre abrégé: J Surg Orthop Adv
Pays: United States
ID NLM: 101197881

Informations de publication

Date de publication:
2024
Historique:
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 30 5 2024
Statut: ppublish

Résumé

Dehydration is an overlooked modifiable risk factor that should be optimized prior to elective total hip arthroplasty (THA) to reduce postoperative complications and inpatient costs. All primary THA from 2005 - 2019 were queried from the National Surgical Quality Improvement Program database, and patients were compared based on dehydration status: blood urea nitrogen (BUN): creatinine ratio (Cr) (BUN/Cr) < 20 (nondehydrated), 20 ≤ BUN/Cr ≤ 25 (moderately dehydrated), 25 < BUN/Cr (severely dehydrated). A subgroup analysis involving only elderly patients > 65 years and normalized gender-adjusted Cr values was also performed. The analysis included 212,452 patients who underwent THA. Adjusted multivariate logistic regression analysis showed that the severely dehydrated cohort had a greater risk of overall complications, postoperative anemia requiring transfusion, nonhome discharge, and increased length of stay (all p < 0.01). Among the elderly, dehydrated patients had a greater risk of postoperative transfusion, cardiac complications, and nonhome discharge (all p < 0.01). BUN/Cr > 20 is an important preoperative diagnostic tool to identify at-risk dehydrated patients. Providers should optimize dehydration to prevent complications, decrease costs, and improve discharge planning. (Journal of Surgical Orthopaedic Advances 33(1):017-025, 2024).

Identifiants

pubmed: 38815073
pii: https://www.jsoaonline.com/archive/2024/spring-2024/preoperative-dehydration-is-an-underrecognized-modifiable-risk-factor-in-total-hip-arthroplasty/

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-25

Auteurs

Brandon E Lung (BE)

UC Irvine Department of Orthopaedic Surgery, Orange, California.

Matthew Kim (M)

Stony Brook Department of Orthopaedic Surgery, Stony Brook, New York.

Kylie Callan (K)

UC Irvine Department of Orthopaedic Surgery, Orange, California.

Maddison McLellan (M)

UC Irvine Department of Orthopaedic Surgery, Orange, California.

Edward D Wang (ED)

Stony Brook Department of Orthopaedic Surgery, Stony Brook, New York.

William McMaster (W)

UC Irvine Department of Orthopaedic Surgery, Orange, California.

Steven Yang (S)

UC Irvine Department of Orthopaedic Surgery, Orange, California.

David H So (DH)

UC Irvine Department of Orthopaedic Surgery, Orange, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH